Publications

The circulating level of FABP3 is an indirect biomarker of microRNA-1.

Varrone F

J Am Coll Cardiol. 2012 Nov 7;61(1):88-95. doi: 10.1016/j.jacc.2012.08.1003

Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy.

Zaglia T

J Clin Invest. 2014 May 1;124(6):2410-24. doi: 10.1172/JCI66339

Neutrophils promote Alzheimer’s disease-like pathology and cognitive decline via LFA-1 integrin.

Zenaro E

Nat Med. 2015 Jul 27;21(8):880-6. doi: 10.1038/nm.3913

Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs.

Di Mauro V

Nanomedicine (Lond). 2016 Mar 16;11(8):891-906. doi: 10.2217/nnm.16.26

Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function.

Rusconi F

Circulation. 2016 Aug 2;134(7):534-46. doi: 10.1161/CIRCULATIONAHA.116.021347

Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy.

Zaglia T

Proc Natl Acad Sci U S A. 2017 Oct 9;114(43):E9006-E9015. doi: 10.1073/pnas.1708772114

Inhalation of peptide-loaded nanoparticles improves heart failure.

Miragoli M

Sci Transl Med. 10(424)pii: eaan6205. doi: 10.1126/scitranslmed.aan6205

Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells.

Di Mauro V

Sci Rep. 2019 Jun 27;9(1):9320. doi: 10.1038/s41598-019-45818-4

Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.

Prondzynski M

EMBO Mol Med. 2019 Nov 3;11(12):e11115. doi: 10.15252/emmm.201911115

Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology.

Ameri P

Int J Mol Sci. 2020 Feb 11;21(4)doi: 10.3390/ijms21041192